OP White Papers - random
-
Patented Process For Olopatadine HCl API Intermediates
7/15/2026
See how this patented Wittig-based process for olopatadine HCl achieves Z/E isomer ratios up to 4:1, eliminating dangerous reagents like n-butyl lithium while cutting purification complexity.
-
Continuous Flow — An Emerging Alternative
3/17/2026
Gain insights on transitioning from batch to continuous flow processes, the benefits of continuous flow chemistry, and ensuring regulatory compliance with Quality by Design (QbD) principles.
-
Essential Strategies For Effective Viral Clearance Studies In Biologics Manufacturing
4/2/2026
Strengthen your viral safety strategy by applying science- and risk-based approaches to viral clearance planning, ensuring robust data, regulatory compliance, and patient protection.
-
Optimizing Charge And N-glycan Profiles For CHO-Derived Fusion Proteins
9/24/2025
Discover how structured design-of-experiment approaches can optimize charge variants and glycosylation to enhance biologics quality and therapeutic performance.
-
Seasonal Vaccine Manufacturing: 3 Areas To Evaluate When Selecting A Partner
10/16/2024
Experienced outsourcing partners will have the right facility and technical capabilities, a culture of speed and execution, and shared expectations and commitment to continuous improvement.
-
Empowering Antibody Discovery With ProSpeed™
11/25/2025
Integrating linear expression technology into single B cell workflows accelerates antibody discovery, enabling early functional screening, improved sensitivity, and cost-effective identification of diverse therapeutic candidates.
-
Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer
3/24/2025
Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
Handle Single-Use Technology Biopharma Waste: Data Sharing, Collaboration
7/7/2025
Learn more about data sharing and collaboration to enable a better environmental impact of single-use technologies (SUTs) and quantifying the single-use plastic waste generated when manufacturing mAbs.
-
How To Maximize Pipeline Value And Enhance eNPV
6/9/2026
Find out how reducing vendor fragmentation can improve program continuity, minimize delays, and support more predictable development outcomes.
-
Analytical Approach For Bispecific Antibody Quality Study
11/25/2025
Bispecific antibody quality control demands advanced analytics to detect mispaired species, assess structural integrity, and confirm potency, ensuring safety and efficacy across diverse therapeutic applications.